Drug Discovery

A new multi-million-dollar investment is poised to reshape the landscape of cancer research by focusing intensely on the unique health challenges faced by the communities of South Texas. The Cancer Prevention Research Institute of Texas (CPRIT) has announced a significant financial commitment of

Within the intricate machinery of our cells, protein kinases serve as the master regulators, orchestrating a vast network of signals that control everything from cell growth to immune responses. They achieve this control through phosphorylation, the process of attaching a phosphate group to a

Within the burgeoning field of regenerative medicine, the value of umbilical cord blood as a potent and ethically sound source of life-saving stem cells is universally recognized, offering transformative treatments for a spectrum of conditions from genetic disorders to hematologic cancers. The

We're speaking with biopharma expert Ivan Kairatov about a groundbreaking study that uses artificial intelligence to decode one of the immune system's fundamental secrets: how antibodies are built. For decades, a key assumption about antibody assembly has shaped therapeutic design, but a new AI

The acidic microenvironment of a solid tumor, once considered a mere byproduct of metabolism, is now being repurposed as a precise trigger for a new generation of cancer-killing vaccines designed to overcome the limitations of conventional immunotherapies. The development of pH-responsive

For decades, the story of how ADHD medications work seemed straightforward: they helped the brain focus. But recent research has completely upended that long-held belief. Today, we're speaking with Ivan Kairatov, a biopharma expert at the forefront of neuroscience and innovation. He’s here to